MILabs

We are able to transition seamlessly between translation studies spanning from imaging phantoms to in vivo murine models. We are glad to have the latest spectral (multi-energy) CT system which enables non-invasive imaging and quantification of various components simultaneously in small animals. We are fortunate to have the MARS scanner at HKU Department of Diagnostic Radiology with it state-of-the-art photon-counting detectors and multi-spectral energy capability. MARS Bioimaging Ltd (MBI) was founded in 2007 to commercialize the cutting-edge Medipix technology and bring photon-counting CT to the clinic. MBI has established itself as the world’s leading research and development group in spectral molecular imaging, and to-date has delivered the world’s first commercial pre-clinical spectral CT scanner. MBI works closely with customers to provide a wide range of spectral imaging solutions for applications ranging from cancer detection to development of novel contrast agents. Mark Figgitt is a highly respected executive and director with four decades of technology and leadership experience, including leading growth for health software, cardiology and radiology providers, Change Healthcare ANZ and HSTM Group NZ for the past six years. Professor Anthony Butler is a clinical radiologist with an interest in developing new imaging technologies.

MOLECUBES builds preclinical imaging CUBES that enable researchers to perform high-performance SPECT/CT and PET/CT studies without the need for complex system handling and even if laboratory space is very limited. Our team, with its roots in scientific research, combines more than 20 years of experience in hardware and software development. MOLECUBES is well aware of the many challenges faced by researchers and focuses on a fluent and user-friendly workflow that puts high quality output, increased throughput and ease of use at its center. Our application team is here to support all our clients in getting the most out of their imaging setup. They provide the necessary training and application support for all research-related questions: scanning protocols, setting up the study, postprocessing, etc.

We are pleased to announce our new 3T PET/MRI small animal camera. As part of the Euro-BioImaging ERIC, the services provided by our facility will be open to all scientists, regardless of their discipline or affiliation. As a member of the MEDISO Group our company provides state-of-the-art PET/CT examinations in Budapest and Debrecen and also isotope diagnostics and therapy in Debrecen which is the largest nuclear medicine center in Central-Eastern Europe. Among routine diagnostic imaging procedures positron emission tomography (PET) and single photon emission computed tomography (SPECT) combined with computed tomography (CT) or magnetic resonance imaging (MRI) currently belong to the most advanced techniques in the world. Among the routine diagnostic imaging procedures positron emission tomography and single photon emission computed the same position.

Mediso Medical Imaging Systems with headquarters in Budapest is a dynamic supplier of Nuclear Medicine and modern Hybrid Imaging techniques to the health care and medical research institutions of the world. More than 50% of Mediso employees are engaged with R&D. The Mediso-affiliated USA, German, Polish, Belgian and English subsidiaries and the wordwide distributor network ensures close contact with our customers and offers quick response for their requests. More than 1550 Mediso cameras are installed in more than 100 countries worldwide. Mediso operates two PET-CT and nuclear medicine centres at the University of Debrecen and in Budapest. Mediso acquired the NM profile of Gamma Works. Launching the first Mediso preclinical system the nanoSPECT/CT. Mediso takes on NM clinical diagnostic service profile acquiring ScanoMed Ltd.

Years of experience innovating patented small animal imaging technology. Used in 450 published papers, the MICRON platform delivers seven essential modalities in a compact footprint, backed by world-class service, that's ideal for the exacting data capture. The ability to capture video, select and output individual frames later is a big help when focusing on the retina in the small rodent eye.".

Our team of dedicated scientists have broad experience in targeted drug delivery. Within the Amsterdam UMC Imaging Center, we have access to state-of-the-art facilities including radioactive tracer production facilities, chemical and biochemical laboratories, preclinical facilities, and preclinical- and clinical Imaging equipment (PET/CT, PET/MRI). Our scientific and technical staff are located in the Amsterdam Imaging Center: an award-winning facility in which all disciplines required for image-guided drug development - from organic tracer chemistry to clinical diagnostics - are unified under one single roof.